<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns="http://purl.org/rss/1.0/"
         xmlns:admin="http://webns.net/mvcb/"
         xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
  <channel rdf:about="https://hstalks.com/rss/by-category/754/">
    <title>Pharmaceutical Sciences</title>
    <link>https://hstalks.com/category/754/pharmaceutical-sciences/?biosci</link>
    <description>New and updated series &amp; talks on Pharmaceutical Sciences from HSTalks&#x27; Biomedical &amp; Life Sciences Collection.</description>
    <admin:generatorAgent rdf:resource="http://www.hstalks.com/" />
    <admin:errorReportsTo rdf:resource="mailto:info@hstalks.com" />
    <sy:updatePeriod>daily</sy:updatePeriod>
    <sy:updateFrequency>1</sy:updateFrequency>
    <sy:updateBase>2006-01-01T12:00+00:00</sy:updateBase>
    <dc:publisher>Henry Stewart Talks</dc:publisher>
    <dc:language>en</dc:language>
    <dc:rights>© Copyright Henry Stewart Talks Ltd.</dc:rights>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
    <prism:copyright>© Copyright Henry Stewart Talks Ltd.</prism:copyright>
    <items>
      <rdf:Seq>
      <rdf:li resource="https://hstalks.com/t/21838/current-emerging-therapies-for-the-management-of-p/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20947/ich-s2-genotoxicity/?biosci" />
      <rdf:li resource="https://hstalks.com/t/18440/drug-refinement/?biosci" />
      <rdf:li resource="https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21783/emergency-drug-administration-paramedic-context/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20221/raav-gene-therapy-manufacturing-analysis-comparabi/?biosci" />
      <rdf:li resource="https://hstalks.com/t/17779/drug-pharmacokinetics/?biosci" />
      <rdf:li resource="https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci" />
      <rdf:li resource="https://hstalks.com/t/18439/chemical-synthesis/?biosci" />
      <rdf:li resource="https://hstalks.com/t/22564/sterile-technique-in-the-lab/?biosci" />
      <rdf:li resource="https://hstalks.com/t/18275/pediatric-research-technical-logistical-considerat/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21774/pharmaceutical-biotechnology/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21778/cholesterol-biosynthesis-and-statins/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21096/kalihinol-analog-med6-189-a-promising-pan-antimala/?biosci" />
      
      </rdf:Seq>
    </items>
  </channel>

  <item rdf:about="https://hstalks.com/t/21838/current-emerging-therapies-for-the-management-of-p/?biosci">
    <title>Current &amp; emerging therapies for the management of patients with endometrial cancer [42 mins] </title>
    <link>https://hstalks.com/t/21838/current-emerging-therapies-for-the-management-of-p/?biosci</link>
    <description>Endometrial cancer - Classification of endometrial cancer - Single agent immunotherapy in biomarker selected endometrial cancers - First-line treatment of advanced or recurrent endometrial cancer - Adding PARP inhibition to first line - Adjuvant therapy - Antibody drug conjugates in endometrial cancer - Cell cycle checkpoint inhibitors in endometrial cancers - Hormonal therapy - Biomarker based therapy</description>
    <dc:title>Current &amp; emerging therapies for the management of patients with endometrial cancer</dc:title>
    
    <dc:creator>Prof. Brian Slomovitz</dc:creator>
    
    <dc:subject>Endometrial cancer, Classification of endometrial cancer, Single agent immunotherapy in biomarker selected endometrial cancers, First-line treatment of advanced or recurrent endometrial cancer, Adding PARP inhibition to first line, Adjuvant therapy, Antibody drug conjugates in endometrial cancer, Cell cycle checkpoint inhibitors in endometrial cancers, Hormonal therapy, Biomarker based therapy</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20947/ich-s2-genotoxicity/?biosci">
    <title>ICH S2 genotoxicity [14 mins] </title>
    <link>https://hstalks.com/t/20947/ich-s2-genotoxicity/?biosci</link>
    <description>ICH S2A &amp; S2B guidelines - Standard battery for genotoxicity testing in S2B - Major revised points of the S2(R1) guideline - In vitro &amp; in vivo genotoxicity tests - Revisions to guidelines</description>
    <dc:title>ICH S2 genotoxicity</dc:title>
    
    <dc:creator>Dr. Masamitsu Honma</dc:creator>
    
    <dc:subject>ICH S2A &amp; S2B guidelines, Standard battery for genotoxicity testing in S2B, Major revised points of the S2(R1) guideline, In vitro &amp; in vivo genotoxicity tests, Revisions to guidelines</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/18440/drug-refinement/?biosci">
    <title>Drug refinement [4 mins] </title>
    <link>https://hstalks.com/t/18440/drug-refinement/?biosci</link>
    <description>Hit and lead - High throughput screening - Lead optimisation - Cycle of drug testing - Drug optimisation and refinement</description>
    <dc:title>Drug refinement</dc:title>
    
    <dc:creator>Dr. Wayne Carter</dc:creator>
    
    <dc:subject>Hit and lead, High throughput screening, Lead optimisation, Cycle of drug testing, Drug optimisation and refinement</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci">
    <title>Unlocking a cryptic pocket: a new approach to safer pain relief [8 mins] </title>
    <link>https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci</link>
    <description>CB1 receptor agonists - Cryptic pocket drug design - Molecular dynamics simulations - Peripheral pain therapeutics - Biased GPCR signalling - Tolerance reduction in cannabinoid therapies - Allosteric/sodium binding sites - Translation of analgesic drug candidates (VIP36) to the clinic</description>
    <dc:title>Unlocking a cryptic pocket: a new approach to safer pain relief</dc:title>
    
    <dc:creator>Prof. Susruta Majumdar</dc:creator>
    <dc:creator>Dr. Vipin Ashok Rangari</dc:creator>
    
    <dc:subject>CB1 receptor agonists, Cryptic pocket drug design, Molecular dynamics simulations, Peripheral pain therapeutics, Biased GPCR signalling, Tolerance reduction in cannabinoid therapies, Allosteric/sodium binding sites, Translation of analgesic drug candidates (VIP36) to the clinic</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21783/emergency-drug-administration-paramedic-context/?biosci">
    <title>Emergency drug administration (paramedic context) [4 mins] </title>
    <link>https://hstalks.com/t/21783/emergency-drug-administration-paramedic-context/?biosci</link>
    <description>Emergency drug admin principles - Rapid accurate drug delivery - Drug delivery routes and selection - Common emergency medications overview - Patient assessment and monitoring - Documentation and communication in emergency care</description>
    <dc:title>Emergency drug administration (paramedic context)</dc:title>
    
    
    <dc:subject>Emergency drug admin principles, Rapid accurate drug delivery, Drug delivery routes and selection, Common emergency medications overview, Patient assessment and monitoring, Documentation and communication in emergency care</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20221/raav-gene-therapy-manufacturing-analysis-comparabi/?biosci">
    <title>rAAV gene therapy: manufacturing, analysis &amp; comparability [27 mins] </title>
    <link>https://hstalks.com/t/20221/raav-gene-therapy-manufacturing-analysis-comparabi/?biosci</link>
    <description>Manufacturing process overview - Development and challenges in manufacturing process - Analytical considerations: critical quality attributes and challenges - Comparability assessment - Evaluation of analytical comparability results - Key regulatory guidance on comparability - Summary of statistical methods - Equivalence test</description>
    <dc:title>rAAV gene therapy: manufacturing, analysis &amp; comparability</dc:title>
    
    <dc:creator>Dr. Courtney Sloan</dc:creator>
    <dc:creator>Dr. Aili Cheng</dc:creator>
    
    <dc:subject>Manufacturing process overview, Development and challenges in manufacturing process, Analytical considerations: critical quality attributes and challenges, Comparability assessment, Evaluation of analytical comparability results, Key regulatory guidance on comparability, Summary of statistical methods, Equivalence test</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/17779/drug-pharmacokinetics/?biosci">
    <title>Drug pharmacokinetics [7 mins] </title>
    <link>https://hstalks.com/t/17779/drug-pharmacokinetics/?biosci</link>
    <description>Drug metabolism - ADME - Designing drugs - Route of administration - Drug delivery - Characteristics of a successful drug</description>
    <dc:title>Drug pharmacokinetics</dc:title>
    
    <dc:creator>Dr. Wayne Carter</dc:creator>
    
    <dc:subject>Drug metabolism, ADME, Designing drugs, Route of administration, Drug delivery, Characteristics of a successful drug</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci">
    <title>Interpreting non-clinical toxicity studies in psychiatric drug development: human relevance and safety [16 mins] </title>
    <link>https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci</link>
    <description>Psychiatric drug development - Challenges in early drug development - Challenges associated with lifelong treatment - Non-clinical toxicity studies - Toxicity studies for psychiatric therapeutics - Relevance to human safety</description>
    <dc:title>Interpreting non-clinical toxicity studies in psychiatric drug development: human relevance and safety</dc:title>
    
    <dc:creator>Dr. Yael Mandelblat-Cerf</dc:creator>
    
    <dc:subject>Psychiatric drug development, Challenges in early drug development, Challenges associated with lifelong treatment, Non-clinical toxicity studies, Toxicity studies for psychiatric therapeutics, Relevance to human safety</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/18439/chemical-synthesis/?biosci">
    <title>Chemical synthesis [5 mins] </title>
    <link>https://hstalks.com/t/18439/chemical-synthesis/?biosci</link>
    <description>Synthesis of chemical entities - Rational drug design - Compound libraries - Phytochemicals as drugs - Scale up</description>
    <dc:title>Chemical synthesis</dc:title>
    
    <dc:creator>Dr. Wayne Carter</dc:creator>
    
    <dc:subject>Synthesis of chemical entities, Rational drug design, Compound libraries, Phytochemicals as drugs, Scale up</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/22564/sterile-technique-in-the-lab/?biosci">
    <title>Sterile technique in the lab [4 mins] </title>
    <link>https://hstalks.com/t/22564/sterile-technique-in-the-lab/?biosci</link>
    <description>Sterile technique principles - Hand hygiene practices - PPE usage - Sterilization methods - Maintaining sterile environment - Environmental monitoring - Pre-analytical phase roles</description>
    <dc:title>Sterile technique in the lab</dc:title>
    
    
    <dc:subject>Sterile technique principles, Hand hygiene practices, PPE usage, Sterilization methods, Maintaining sterile environment, Environmental monitoring, Pre-analytical phase roles</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/18275/pediatric-research-technical-logistical-considerat/?biosci">
    <title>Pediatric research: technical &amp; logistical considerations - post natal ontogeny [21 mins] </title>
    <link>https://hstalks.com/t/18275/pediatric-research-technical-logistical-considerat/?biosci</link>
    <description>Pediatric research rationale - American Academy of Pediatrics guidelines (1995) - ADME summary - Post natal ontogeny: Additional dynamics - Post natal ontogeny medicinal product dosing implications - Dosing approaches - Body surface and weight-based dosing - Age-based dosing: Approximations that require careful monitoring - General pediatric dosing considerations - Dosage forms</description>
    <dc:title>Pediatric research: technical &amp; logistical considerations - post natal ontogeny</dc:title>
    
    <dc:creator>Prof. Steven Hirschfeld</dc:creator>
    
    <dc:subject>Pediatric research rationale, American Academy of Pediatrics guidelines (1995), ADME summary, Post natal ontogeny: Additional dynamics, Post natal ontogeny medicinal product dosing implications, Dosing approaches, Body surface and weight-based dosing, Age-based dosing: Approximations that require careful monitoring, General pediatric dosing considerations, Dosage forms</dc:subject>
    <dc:date>2026-05-28</dc:date>
    <prism:publicationDate>2026-05-28</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21774/pharmaceutical-biotechnology/?biosci">
    <title>Pharmaceutical biotechnology [4 mins] </title>
    <link>https://hstalks.com/t/21774/pharmaceutical-biotechnology/?biosci</link>
    <description>Pharmaceutical biotech advances - Biologic drug development - Large-scale production breakthroughs - Biologic manufacturing complexities - Biologic stability and immune challenges - Biosimilars and gene editing solutions - Regulatory landscape and impact</description>
    <dc:title>Pharmaceutical biotechnology</dc:title>
    
    
    <dc:subject>Pharmaceutical biotech advances, Biologic drug development, Large-scale production breakthroughs, Biologic manufacturing complexities, Biologic stability and immune challenges, Biosimilars and gene editing solutions, Regulatory landscape and impact</dc:subject>
    <dc:date>2026-05-28</dc:date>
    <prism:publicationDate>2026-05-28</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21778/cholesterol-biosynthesis-and-statins/?biosci">
    <title>Cholesterol biosynthesis and statins [4 mins] </title>
    <link>https://hstalks.com/t/21778/cholesterol-biosynthesis-and-statins/?biosci</link>
    <description>Cholesterol biosynthesis pathway - Regulation of hepatic cholesterol - Statin mechanism of action - Statin clinical uses and benefits - Statin side effects and monitoring</description>
    <dc:title>Cholesterol biosynthesis and statins</dc:title>
    
    
    <dc:subject>Cholesterol biosynthesis pathway, Regulation of hepatic cholesterol, Statin mechanism of action, Statin clinical uses and benefits, Statin side effects and monitoring</dc:subject>
    <dc:date>2026-05-28</dc:date>
    <prism:publicationDate>2026-05-28</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21096/kalihinol-analog-med6-189-a-promising-pan-antimala/?biosci">
    <title>Kalihinol analog MED6-189: a promising pan-antimalarial candidate [13 mins] </title>
    <link>https://hstalks.com/t/21096/kalihinol-analog-med6-189-a-promising-pan-antimala/?biosci</link>
    <description>Antimalarial drug discovery - Natural product analogues (Kalinol) - Drug-resistant Plasmodium falciparum - Mechanism of action studies - Apicoplast targeting - Vesicular trafficking pathways - Semi-synthetic compound (MED6-189) - Preclinical development and translational challenges</description>
    <dc:title>Kalihinol analog MED6-189: a promising pan-antimalarial candidate</dc:title>
    
    <dc:creator>Prof. Karine Le Roch</dc:creator>
    
    <dc:subject>Antimalarial drug discovery, Natural product analogues (Kalinol), Drug-resistant Plasmodium falciparum, Mechanism of action studies, Apicoplast targeting, Vesicular trafficking pathways, Semi-synthetic compound (MED6-189), Preclinical development and translational challenges</dc:subject>
    <dc:date>2026-05-28</dc:date>
    <prism:publicationDate>2026-05-28</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

</rdf:RDF>
